Published On: Wed, Nov 30th, 2022
World | By

Alzheimer’s drug slowed cognitive decline overall in trial, but with major side effects for some


An experimental Alzheimer’s disease drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of dangerous side effects for certain patients, according to new data presented on Tuesday.

CBC | World News